Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results
Boston Scientific (NYSE: BSX) has announced two upcoming investor events.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Boston Scientific (NYSE: BSX) has announced two upcoming investor events. The company will host its 2025 Investor Day on September 30, 2025, at 8:30 a.m. ET in a hybrid format, where management will discuss financial goals and long-term growth strategies.
Additionally, BSX will hold its Q3 2025 earnings conference call on October 22, 2025, at 8:00 a.m. ET. The call will feature Chairman and CEO Mike Mahoney and CFO Jon Monson. Both events will be webcast live and available for replay on the company's investor relations website.
Details
News Market Reaction – BSX
On Sep 2, the day this news came out, BSX closed 1.10% above the previous close.
Data tracked by StockTitan Argus for the Sep 2 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The Investor Day meeting will be held in hybrid format with a simultaneous online webcast. Investors and other interested parties may register for the webcast by visiting the events section on the company's investor website at https://investors.bostonscientific.com. A replay and summary materials from the presentations will also be available online on the website for approximately one year following the event.
Additionally, on Wednesday, October 22, 2025, at 8:00 a.m. ET the company will webcast its conference call discussing financial results and business highlights for the third quarter ending September 30, 2025. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Jon Monson, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the third quarter on October 22 prior to the conference call.
A live webcast and replay for the event will be accessible at https://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and follow us on LinkedIn.
CONTACTS:
Emily Anderson
Media Relations
+1 (617) 515-2000
Emily.Anderson2@bsci.com
Lauren Tengler
Investor Relations
+1 (508) 683-4479
BSXInvestorRelations@bsci.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-2025-investor-day-meeting-and-conference-call-discussing-third-quarter-2025-results-302542246.html
SOURCE Boston Scientific Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.